Auckland's $177m segment recovery masked by Adelaide's $94m loss

Revenue rose 54.6% to $855.8m and EBITDA rose 71.1% to $165.9m, while PBT swung from a $32.8m loss to a $51.7m profit (+257.9%). NPAT, however, was only $8.0m (+123.7% versus the prior loss), held back by an 84.6% effective tax rate that strips most of the PBT recovery out of the bottom line.

Cash performance was materially stronger: operating cash flow tripled to $280.1m and cash on hand rose to $245.0m. Net debt fell to $326.5m and leverage almost halved from 4.96x to 1.97x EBITDA. A final dividend of 6.0 cps was declared.

The Adelaide segment result widened from a $11.1m loss to a $94.1m loss, and the release flags an impairment of the SkyCity Adelaide casino licence alongside ongoing AML cooperation with Australian authorities. Auckland, by contrast, lifted its segment result from $17.8m to $177.2m on $574.8m of revenue. The group recovery is essentially an Auckland story; Adelaide is now subtracting roughly the equivalent of a year's reported NPAT.

PBT is the cleaner operating read this year. PBT growth of +257.9% sits well above NPAT growth of +123.7%, a 134.2 percentage-point gap driven by an 84.6% effective tax rate (versus −2.5% in FY22). The most likely cause is a non-deductible or unrecognised tax effect tied to the Adelaide impairment. For underlying performance, PBT and EBITDA are the better signals; NPAT understates the recovery.

Capital intensity stepped up sharply. Capex rose 154.6% to $254.7m, or 29.8% of revenue versus 18.1% in FY22. That sits alongside borrowings rising $42.1m to $571.5m, and means the strong operating cash flow only converted to about $25.4m of FCF before lease payments. The cash position improved largely because of the operating swing, not free cash generation.

The reported EBITDA of $165.9m is well below that band, which underlines how large the non-recurring and segment items, including the Adelaide impairment, are within the reported number. No forward-year guidance is provided in the supplied excerpts.

The half-year shape is the second concern. H1 FY23 delivered $22.8m of NPAT and $106.3m of EBITDA; the implied H2 contribution is therefore a $14.9m NPAT loss on $59.6m of EBITDA. Whether that H2 softness reflects one-off Adelaide-related charges or genuine trading deceleration is the central read-through into FY24.

OCF/EBITDA of 168.9% (versus 94.0% prior) was helped by lower trade debtors (down $2.8m, with receivable days falling from 7.1 to 3.4) and timing effects on working capital, so this conversion ratio is unlikely to repeat at the same level. Earnings quality, by contrast, is held back by the Adelaide impairment running through reported EBITDA and PBT.

On a durable-earnings basis, Auckland's segment margin lift from 4.9% to 30.8% and Other Operations' lift from 39.4% to 48.9% look genuine and tied to the post-COVID return of customers. The flattering tax position prior, the Adelaide losses now, and the working-capital tailwind all argue that FY23's reported NPAT is not the right anchor for run-rate earnings. The 0.5% ROE shows the bottom-line recovery has not yet translated into a return on the $1.5b equity base.

This briefing cannot assess the size or timing of any further Adelaide-related charges, regulatory penalties, or AML remediation costs beyond what is captured in the reported FY23 numbers.